SeaStar Medical Holding Corporation ICU

Q2 FY2026 · ended Jun 30, 2026 · Revenue $615,000, +82.0% YoY · Filed Aug 12, 2026

SeaStar Medical Holding Corporation (ICU) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $615,000 and a net loss of $3.7 million.

Revenue
$615,000
+82.0% vs year-ago quarter
Net income
$-3.73M
-86.3% vs year-ago quarter
Operating cash flow
$-2.99M
+0.4% vs year-ago quarter
Free cash flow
—
EPS
$-0.18
+59.1% vs prior quarter
Dividend per share
None
Shares outstanding
4.41M
-84.2% vs year-ago quarter
Net cash
$1.25M
Q4 FY2024
Operating margin
-816.6%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ICU (Nasdaq), ICUCW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Denver, CO
SEC filer status
, Emerging growth company
SEC CIK
1831868
Former names
LMF Acquisition Opportunities Inc (until Oct 27, 2022)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$615,000
$495,000
$420,000
$183,000
$338,000
Operating income
-$3.8M
-$3.6M
-$3.0M
-$3.6M
-$1.8M
Net income
-$3.7M
-$3.5M
-$2.9M
-$3.5M
-$2.0M
Diluted EPS
—
—
—
—
-$0.18
Operating cash flow
-$3.0M
-$2.8M
-$4.1M
-$3.8M
-$3.0M
Total assets
$8.6M
$11.3M
$14.2M
$15.5M
$8.4M
Total liabilities
$4.4M
$3.9M
$3.7M
$4.1M
$5.0M
Stockholders' equity
$4.3M
$7.3M
$10.4M
$11.5M
$3.3M
Cash and investments
$7.0M
$9.3M
$12.0M
$13.8M
$6.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 3, 2026 Oct 30, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 5, 2026 Oct 5, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Officer or director change
Jul 1, 2026 Jun 25, 2026
8-K/A Amended current report
Officer or director change
Jun 23, 2026 Aug 13, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.